a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 23, 2021

Primary Completion Date

February 27, 2023

Study Completion Date

February 27, 2023

Conditions
Pulmonary Arterial Hypertension (PAH)
Interventions
OTHER

as per Physician's prescription

Participants need to take the Revatio as per Physician's prescription

Trial Locations (7)

Unknown

Peking Union Medical College Hospital, Beijing

Guangdong Provincial People's Hospital, Guangdong

The Second Xiangya Hospital Of Central South University, Changsha

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

Affiliated Hospital of Jining Medical College, Jining

Tianjin Medical University General Hospital, Tianjin

Yanan Hospital of Kunming City, Kunming

Sponsors
All Listed Sponsors
lead

Pfizer Pharmaceuticals Ltd.

INDUSTRY